Search

Joseph E Palys

Examiner (ID: 1283)

Most Active Art Unit
2413
Art Unit(s)
2413, 2787, 2313, 2899, 2785
Total Applications
453
Issued Applications
351
Pending Applications
23
Abandoned Applications
79

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3506745 [patent_doc_number] => 05562905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals' [patent_app_type] => 1 [patent_app_number] => 7/324027 [patent_app_country] => US [patent_app_date] => 1989-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10613 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/562/05562905.pdf [firstpage_image] =>[orig_patent_app_number] => 324027 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/324027
Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals Mar 19, 1989 Issued
Array ( [id] => 2849750 [patent_doc_number] => 05133960 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-28 [patent_title] => 'Use of TNF and LT for the preparation of drugs' [patent_app_type] => 1 [patent_app_number] => 7/296144 [patent_app_country] => US [patent_app_date] => 1989-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 574 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/133/05133960.pdf [firstpage_image] =>[orig_patent_app_number] => 296144 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/296144
Use of TNF and LT for the preparation of drugs Jan 11, 1989 Issued
07/290497 PHARMACEUTICAL COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF PSORIASIS Dec 26, 1988 Abandoned
07/286477 MONOCLONAL ANTIBODIES TO CACHECTIN/TUMOR NECROSIS FACTOR AND METHODS FOR PREPARING SAME Dec 18, 1988 Abandoned
07/282606 PROTEOLYTIC FRAGMENTS OBTAINED FROM HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN COMPLEX I Dec 11, 1988 Abandoned
07/275309 SYNTHETIC DNA DERIVED RECOMBINANT HIV ANTIGENS Nov 22, 1988 Abandoned
07/269407 CONSTRUCTION OF NON-INFECTIOUS RETROVIRAL MUTANTS DEFICIENT IN VIRAL RNA Nov 9, 1988 Abandoned
07/268322 HIV-2 ENVELOPE POLYPEPTIDES Nov 6, 1988 Abandoned
07/244590 ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) VIRAL ENVELOPE PROTEIN AND METHOD OF TESTING FOR AIDS Sep 12, 1988 Abandoned
07/238937 MACROPHAGE-DERIVED INFLAMMATORY MEDIATOR (MIP-1ALPHA AND MIP 1BETA) Sep 1, 1988 Abandoned
07/239775 VACCINE TO CONTROL THE VIRAL INFECTION OF FISH Sep 1, 1988 Abandoned
07/227568 MOLECULARLY CLONED ACQUIRED IMMUNODEFICIENCY SYNDROME POLYPEPTIDES AND THEIR METHODS OF USE Aug 1, 1988 Abandoned
07/200752 PREVENTION AND TREATMENT OF RETROVIRAL DISEASE May 30, 1988 Abandoned
07/168088 HIV SUBUNIT VACCINE Mar 10, 1988 Abandoned
07/162781 METHOD OF TREATING AUTOIMMUNE AND/OR VIRAL-INDUCED DISEASES THAT ARE MEDIATED BY CD8 PHENOTYPE T CELLS Mar 1, 1988 Abandoned
07/148692 SYNTHETIC ANTIGEN EVOKING ANTI-HIV RESPONSE Jan 25, 1988 Abandoned
07/126007 PRODUCTION OF HUMAN T-CELL LEUKEMIA (LYMPHOTROPIC) RETROVIRUS (HTLV-I) ENVELOPE PROTEIN FRAGMENTS IN BACTERIAL AND USE IN SEROEPIDEMIOLOGICAL STUDIES Nov 26, 1987 Abandoned
07/034874 MONOCLONAL ANTIBODIES RECOGNIZING HUMAN INTERLEUKIN-2-RECEPTOR Apr 5, 1987 Abandoned
06/751771 NOVEL COMPOSITIONS AND METHODS FOR VIRAL VACCINATION Jul 1, 1985 Abandoned
06/358150 FATTY ACID CARRIERS FOR SYNTHETIC VACCINES Mar 14, 1982 Abandoned
Menu